Back to search

Switzerland· 66520003

Olmesartan Amlo Spirig HC 40mg/10mg, Filmtabletten

A olmesartan medoxomil und amlodipin product, registered in Switzerland by Spirig HealthCare AG and dispensed under Swissmedic category B. The same ATC class is registered in 8 of our 19 countries.

Cat B (Swissmedic)ATC C09DB02

Checked against the register on

Informational only — not a medical device.

SOURCE REGISTER · CHPublic registernormalisedOlmesartan Amlo Spirig HC 40mg/10mg, …ATCC09DB02REGISTER NO.66520003PACKS LISTED0CHECKEDJune 26, 2026

Where it is registered

Olmesartan medoxomil und amlodipin is registered in 8 of 19 countries.

Countries holding a registration under ATC C09DB02 (olmesartan medoxomil und amlodipin), each read from that country’s own register.

  • This record: Switzerland
  • 6 of them publish a price we can compare per daily dose

Olmesartan medoxomil und amlodipin · ATC C09DB02

8 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Finlandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Manufacturer
Spirig HealthCare AG
Country
Switzerland (CH)
ATC code
C09DB02
ATC class
Olmesartan medoxomil und Amlodipin
Swissmedic category
B
Reimbursed
No
Last checked
June 26, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

81 interactions on record for olmesartan medoxomil und amlodipin.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Olmesartan medoxomil und amlodipin · interactions on record

81 records

81 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of the issuing authority. This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f61566af-468c-4405-a281-71abfb0df55d
GET /v1/drugs/f61566af-468c-4405-a281-71abfb0df55d?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "source": "swissmedic_auth",
  "heilmittelcode": "Synthetika"
}

See everything about olmesartan medoxomil und amlodipin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.